Logotype for Grown Rogue International Inc

Grown Rogue International (GRIN) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Grown Rogue International Inc

Q2 2025 earnings summary

22 Apr, 2026

Executive summary

  • Achieved positive cash flow from operations despite a $2M+ EBITDA headwind from lower average selling prices year-over-year.

  • Pro forma revenue for Q2 2025 was $8.01M, up 4% year-over-year; pro forma adjusted EBITDA was $1.82M, down 12% year-over-year, reflecting margin pressure from pricing declines and growth investments.

  • Maintained profitability and operational resilience through cost controls and yield improvements.

  • Expansion efforts continue in New Jersey, Illinois, and Minnesota, with new licenses and facility construction underway.

  • Focused on long-term growth, not dependent on federal reform, and leveraging low-cost production as a competitive advantage.

Financial highlights

  • Production costs in Michigan dropped below $400/lbs, Oregon in the mid $400s, with indoor costs estimated sub-$200/lbs.

  • Oregon revenue: $3.08M (down 16% YoY), adjusted EBITDA: $0.80M (26.1% margin); Michigan revenue: $2.28M (down 34% YoY), adjusted EBITDA: $0.78M (34.2% margin); New Jersey affiliate revenue: $2.65M, adjusted EBITDA: $1.29M (48.6% margin).

  • Total flower harvested increased 20% in Oregon and 14% in Michigan year-over-year.

  • Cost per pound produced fell 16% in Oregon and 15% in Michigan year-over-year.

  • Adjusted EBITDA remained strong despite a significant pricing decline in core markets.

Outlook and guidance

  • Expecting continued recovery in Oregon and Michigan pricing after recent troughs.

  • New Jersey phase II construction to complete by early Q2 2026, targeting 1,200 lbs/month capacity.

  • Anticipate capital-efficient growth from distressed industry opportunities over the next 12-18 months.

  • Management expects continued pricing pressure but sees opportunity in distressed industry conditions.

  • No material near-term impact expected from potential federal rescheduling of cannabis.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more